Sahpra warns of falsified diabetes treatments Ozempic and Mounjaro sold online for weight loss, posing health risks.

Eli Lilly has received approval to start selling its weight loss drug, Mounjaro, in Hong Kong as early as the end of this ...

If you looked solely at its stock price, you might get the idea that Eli Lilly (NYSE ... Learn more here. Lilly's newest cash ...

In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

A small player like Viking may also win by attracting a partner or even a company that will offer to acquire the biotech.

AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...

These include knockoffs of popular weight loss drugs. Customs officials allowed CBS News a rare ... FDA has not approved any generic versions of semaglutide." Eli Lilly, makers of Mounjaro and ...

Novo Nordisk reported earnings, posting some chunky year-over-year growth and far outperforming its only real rival at the ...

Novo Nordisk reported forecast-beating third-quarter sales of its popular Wegovy weight-loss drug on Wednesday, reassuring ...

Novo Nordisk reported better-than-expected third-quarter sales for its weight-loss drug Wegovy, calming investor concerns ...

Novo Nordisk's sales of Wegovy surpassed expectations, calming investor concerns about competition from Eli Lilly. Shares ...